Subscribe To
Arvinas announces upcoming bavdegalutamide poster presentation at esmo congress 2023
NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...
October 15, 2023, 10:07 pm
Arvinas and pfizer announce upcoming vepdegestrant (arv-471) poster presentation at esmo congress 2023
NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will p...
October 15, 2023, 10:05 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsenta...
October 13, 2023, 8:30 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI ® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsent...
October 13, 2023, 4:30 pm
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...
October 13, 2023, 2:22 pm
Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting
IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...
October 13, 2023, 11:00 am
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...
October 13, 2023, 10:22 am
Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
October 13, 2023, 9:05 am
Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa
WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...
October 13, 2023, 8:00 am
Pharvaris to present at the apaaaci 2023 international conference
ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...
October 13, 2023, 6:50 am
Nobleai’s science-based ai technology to be highlighted at spe annual technical conference and exposition
How Use of AI-Powered Modeling Sped Multi-Well and Multi-Bench Unconventional Development for ExxonMobil SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE)...
October 12, 2023, 12:05 pm
Iterum therapeutics to present data at idweek 2023
DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c...
October 12, 2023, 9:15 am
Miromatrix to present at the 2023 isodp organ donation congress
EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology ...
October 11, 2023, 8:05 pm
An2 therapeutics to present new data for epetraborole at idweek 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatment...
October 11, 2023, 12:01 am
Children’s home society of nc’s new sexual health education program launches to early success
Greensboro, North Carolina, Oct. 10, 2023 (GLOBE NEWSWIRE) — In January of this year, Children’s Home soci...
October 10, 2023, 5:45 pm
Binance faces regulatory hurdles in meeting uk crypto ad rules
The Financial Conduct Authority (FCA) has disrupted Binance's plans to adhere to the UK's new crypto marketing regulations. This occurred after its UK...
October 10, 2023, 4:49 pm
Nulg: a case where esg investing is working
The article compares the portfolios and performance of the Nuveen ESG Large-Cap Growth ETF to the SPDR Portfolio S&P 500 Growth ETF. ESG investing aim...
October 10, 2023, 6:16 am
Harpoon therapeutics to present interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company deve...
October 9, 2023, 4:17 pm
5 stocks that turned $10,000 into millions, and none of them are tech companies
Nationwide and international expansion has proven lucrative for some retail investors. Others build wealth as ...
October 7, 2023, 9:03 am
Binance prepares for uk's financial promotions regime: introduces dedicated domain
Ahead of the implementation of the UK's newly updated Financial Promotions Regime, Binance has unveiled a dedicated domain for its users in the UK. Th...
October 6, 2023, 9:26 pm